- Home
- VNRX vs RNXT Comparison
VNRX vs RNXT Comparison
Compare VNRX & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- RNXT
- Stock Information
- Founded
- VNRX N/A
- RNXT 2012
- Country
- VNRX United States
- RNXT United States
- Employees
- VNRX N/A
- RNXT N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- VNRX Health Care
- RNXT Health Care
- Exchange
- VNRX Nasdaq
- RNXT Nasdaq
- Market Cap
- VNRX 52.4M
- RNXT 44.6M
- IPO Year
- VNRX N/A
- RNXT 2021
- Fundamental
- Price
- VNRX $0.80
- RNXT $1.36
- Analyst Decision
- VNRX Strong Buy
- RNXT Strong Buy
- Analyst Count
- VNRX 5
- RNXT 2
- Target Price
- VNRX $3.88
- RNXT $7.25
- AVG Volume (30 Days)
- VNRX 307.1K
- RNXT 190.1K
- Earning Date
- VNRX 08-13-2025
- RNXT 08-12-2025
- Dividend Yield
- VNRX N/A
- RNXT N/A
- EPS Growth
- VNRX N/A
- RNXT N/A
- EPS
- VNRX N/A
- RNXT N/A
- Revenue
- VNRX $1,308,361.00
- RNXT $240,000.00
- Revenue This Year
- VNRX $563.72
- RNXT $3,186.05
- Revenue Next Year
- VNRX $160.43
- RNXT $291.93
- P/E Ratio
- VNRX N/A
- RNXT N/A
- Revenue Growth
- VNRX 64.16
- RNXT N/A
- 52 Week Low
- VNRX $0.40
- RNXT $0.75
- 52 Week High
- VNRX $0.94
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- VNRX 75.61
- RNXT 58.97
- Support Level
- VNRX $0.40
- RNXT $1.26
- Resistance Level
- VNRX $0.75
- RNXT $1.40
- Average True Range (ATR)
- VNRX 0.08
- RNXT 0.05
- MACD
- VNRX 0.02
- RNXT -0.01
- Stochastic Oscillator
- VNRX 69.33
- RNXT 48.70
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.